Novartis' Entresto infringes on university patents, lawsuit claims

More than a year and a half after securing FDA approval for a blockbuster heart drug, Novartis is now going to court over it.

Novartis was served with a federal lawsuit earlier this week in the Northern District of California, alleging that its heart failure treatment Entresto infringes a patent jointly held by the University of Michigan and the University of South Florida related to “engineering crystals for the design of new drug compounds.”